vascular malformations

Advertisement

cGxPJobs Banner

Palvella Therapeutics Wins 2026 PACT Healthcare & Life Sciences Company of the Year Award

WAYNE, Pa., May 21, 2026 Palvella Therapeutics announced that it has been named Healthcare & Life Sciences Company of...

By cGxPwire Editor
May 22, 2026

Read More

Palvella Reports Positive Phase 2 Data for QTORIN in Venous Malformations

WAYNE, Pa., May 15, 2026 Palvella Therapeutics announced new positive Phase 2 TOIVA trial data for QTORIN™ rapamycin in...

By cGxPwire Editor
May 16, 2026

Read More

Advertisement

cGxPJobs

Directory